Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75-225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study.

Kornstein SG; Ahmed S; Friedman ES; Yan B; Ninan PT; Keller M

首页> 外文期刊>International clinical psychopharmacology >Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75-225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study.

【24h】

Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75-225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study.

机译：在复发性重度抑郁症患者中评估使用文拉法辛缓释75-225 mg /天维持治疗2年的疗效：对PREVENT研究数据的二次分析。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The objective of this study was to evaluate the long-term efficacy of venlafaxine extended release (ER)

机译：这项研究的目的是评估文拉法辛缓释（ER）≥225mg /天对复发性重度抑郁症（MDD）患者的长期疗效。在该双盲试验中，将患有复发性MDD（N = 1096）的门诊患者随机分为10周，分别接受文拉法辛ER（75-300 mg /天）或氟西汀（20-60 mg /天）的急性期治疗，然后再给予6个月的延续阶段和两个连续的12个月维护阶段。在每个维持期开始时，文拉法辛ER反应者被随机分为双盲文拉法辛ER或安慰剂。在此分析中，在接受维拉法辛ER

著录项

来源
《International clinical psychopharmacology》 |2008年第6期|共7页
作者
Kornstein SG; Ahmed S; Friedman ES; Yan B; Ninan PT; Keller M;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词
venlafaxine; mg; Estrogen Receptors; therapeutic aspects; Analysis of substances;

机译：文拉法辛;毫克;雌激素受体;治疗方面;物质分析;

相似文献

外文文献
中文文献
专利

1. Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75-225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study. [J] . Kornstein SG, Ahmed S, Friedman ES, International clinical psychopharmacology . 2008,第6期

机译：在复发性重度抑郁症患者中评估使用文拉法辛缓释75-225 mg /天维持治疗2年的疗效：对PREVENT研究数据的二次分析。
2. Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release. [J] . Trivedi MH, Dunner DL, Kornstein SG, Journal of affective disorders . 2010,第3期

机译：在使用文拉法辛缓释维持治疗的2年中，复发性重度抑郁症患者的社会心理结果。
3. Influence of sex and menopausal status on response, remission, and recurrence in patients with recurrent major depressive disorder treated with venlafaxine extended release or fluoxetine: Analysis of data from the PREVENT study [J] . KornsteinS.G., PedersenR.D., HollandP.J., The journal of clinical psychiatry . 2014,第1期

机译：性和更年期状态对使用文拉法辛缓释或氟西汀治疗的复发性重度抑郁症患者的反应，缓解和复发的影响：来自PREVENT研究的数据分析
4. A comparison of the effects of treatment options for depression on glycosylated hemoglobin levels of a population of type 2 diabetics: A secondary data analysis. [D] . Ostrowski, MaryLynn. 2007

机译：抑郁症治疗选择对2型糖尿病人群糖基化血红蛋白水平的影响比较：二级数据分析。
5. Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75–225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study [O] . Susan G. Kornstein, James H. Kocsis, Saeeduddin Ahmed, -1

机译：在复发性重度抑郁症患者中评估使用文拉法辛75-225 mg /天的2年维持治疗的有效性：PREVENT研究数据的二次分析
6. Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75–225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study [O] . Susan G. Kornstein, James H. Kocsis, Saeeduddin Ahmed, 2008

机译：评估2年与venlafaxine延长患者的维持治疗的疗效75-225 mg /天，患者复发性重大抑郁症患者：从预防研究中的数据分析

Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75-225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study.

摘要

著录项

相似文献

相关主题

期刊订阅